← All organizations
Highest phase reached
Phase 3
Timeline
2000s
- Jun 1, 2009
RedHill Biopharma— Founded
2010s
- Nov 16, 2018
rifamycin— Marketing Organization
- Nov 1, 2019
procaine benzylpenicillin— NDA Secondary Org
Drugs by trial phase (10 distinct, 19 trials)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
- Bronchiectasis
- Carcinoma
- Carcinoma, Hepatocellular
- Cholangiocarcinoma
- Coronavirus Infections
- Crohn Disease
- Diarrhea
- Dyspepsia
- Gastritis
- Gastroenteritis
- Infections
- Irritable Bowel Syndrome
- Klatskin Tumor
- Lung Diseases
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Multiple Myeloma
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Mycobacterium avium-intracellulare Infection
- Mycobacterium Infections
- Neoplasms, Plasma Cell
- Paratuberculosis
- Pneumonia
- Sarcoma
- Sarcoma, Kaposi
- Sclerosis
- Severe Acute Respiratory Syndrome
- Syndrome
- Vomiting
Marketed drugs (6)
Recent trials (27)
- NCT03414489Lead sponsorN/A—
- NCT05954286CollaboratorPhase 2Sep 30, 2023
- NCT04723537Lead sponsorPhase 2/Phase 3Feb 16, 2021
- NCT04723537Study directorPhase 2/Phase 3Feb 16, 2021
- NCT04616924Study chairPhase 3Dec 1, 2020
- NCT04616924Lead sponsorPhase 3Dec 1, 2020
- NCT04502069Study directorPhase 1/Phase 2Aug 31, 2020
- NCT04502069Lead sponsorPhase 1/Phase 2Aug 31, 2020
- NCT04467840Study directorPhase 2/Phase 3Aug 21, 2020
- NCT04467840Lead sponsorPhase 2/Phase 3Aug 21, 2020
- NCT04414618Study directorPhase 2May 29, 2020
- NCT04414618Lead sponsorPhase 2May 29, 2020
- NCT03377179Lead sponsorPhase 2Mar 7, 2018
- NCT03198507Lead sponsorPhase 3Jun 18, 2017
- NCT03009396Lead sponsorPhase 3Mar 18, 2017
Details
- Founded
- Tel Aviv, IL Jun 1, 2009
- Last known activity
- Sep 30, 2023